Eventide Asset Management - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 48 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2021$1,300,000
-63.6%
960,000
-62.6%
0.02%
-65.5%
Q4 2020$3,570,000
+20.5%
2,569,000
+20.1%
0.06%
-5.2%
Q3 2020$2,963,000
+63.0%
2,139,000
+96.8%
0.06%
+45.0%
Q2 2020$1,818,000
+30.0%
1,087,0000.0%0.04%
-11.1%
Q1 2020$1,398,000
-30.0%
1,087,000
-16.4%
0.04%
-19.6%
Q4 2019$1,997,000
+45.6%
1,300,000
+30.0%
0.06%
+24.4%
Q3 2019$1,372,0001,000,0000.04%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Mint Tower Capital Management B.V. 4,000,000$5,539,0000.72%
SHENKMAN CAPITAL MANAGEMENT INC 4,369,000$6,113,0000.64%
Context Capital Management, LLC 3,000,000$4,169,0000.57%
CSS LLC/IL 4,527,000$6,272,0000.24%
MACKAY SHIELDS LLC 22,388,000$31,068,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 5,931,000$8,177,0000.17%
Calamos Advisors LLC 21,268,000$29,654,0000.17%
PALISADE CAPITAL MANAGEMENT, LP 3,600,000$4,986,0000.13%
LOOMIS SAYLES & CO L P 603,276$57,824,0000.08%
Teton Advisors, Inc. 337,000$470,0000.07%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders